Figure 2. Expression level of AGR2 splice variants in benign and prostate cancer.

Total RNA isolated from benign and prostate carcinoma biopsies was used for cDNA synthesis and qRT-PCR was carried out with AGR2 splice variant specific primers. The results are presented as scatter plot of the expression level of the AGR2 splice variants relative to the level of expression of the human ribosomal subunit 36B4 (* represents p ≤ 0.05).